Current challenges and future prospects in management of neuropathic pain

References

• Jain KK. Central neuropathic pain. In: Medlink Neurology. Gilman S (Ed.) Medlink Corporation, CA, USA (2008).
   Google Scholar
• Treede RD, Jensen TS, Campbell JN et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology70, 1630–1635 (2008).
   PubMed Web of Science ®Google Scholar
• Jain KK. Pain Therapeutics – Drugs, Markets and Companies. Jain PharmaBiotech Publications, Basel, Switzerland (2008).
   Google Scholar
• Moulin DE, Clark AJ, Gilron I et al. Pharmacological management of chronic neuropathic pain – consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag.12, 13–21 (2007).
   PubMed Web of Science ®Google Scholar
• Gray P. Pregabalin in the management of central neuropathic pain. Expert Opin. Pharmacother.8, 3035–3041 (2007).
   PubMed Web of Science ®Google Scholar
• Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst. Rev.4, CD005454 (2007).
   PubMedGoogle Scholar
• Jain KK. Chronic pain. In: Medlink Neurology. Gilman S (Ed.) Medlink Corporation, CA, USA (2008).
   Google Scholar
• Attal N, Cruccu G, Haanpää M et al. EFNS guidelines on pharmacological treatment of neuropathic pain. Eur. J. Neurol.13, 1153–1169 (2006).
   PubMed Web of Science ®Google Scholar
• Chu LF, Angst MS, Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin. J. Pain24, 479–496 (2008).
   PubMed Web of Science ®Google Scholar
• Bowsher D. The management of central post-stroke pain. Postgrad. Med. J.71, 598–604 (1995).
   PubMed Web of Science ®Google Scholar
• Tremont-Lukats IW, Challapalli V, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth. Analg.101, 1738–1749 (2005).
   PubMed Web of Science ®Google Scholar
• Dworkin RH, O’Connor AB, Backonja M et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain132, 237–251 (2007).
   PubMed Web of Science ®Google Scholar
• Finnerup NB, Biering-Sorensen F, Johannesen IL et al. Intravenous lidocaine relieves spinal cord injury pain: a randomized controlled trial. Anesthesiology102, 1023–1030 (2005).
   PubMed Web of Science ®Google Scholar
• Jain KK. Ziconotide. In: Medlink Neurology. Gilman S (Ed.) Medlink Corporation, CA, USA (2008).
   Google Scholar
• Kautio AL, Haanpää M, Saarto T, Kalso E. Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms. J. Pain Symptom Manage.35, 31–39 (2008).
   PubMed Web of Science ®Google Scholar
• Nieto FR, Entrena JM, Cendan CM, Pozo ED, Vela JM, Baeyens JM. Tetrodotoxin inhibits the development and expression of neuropathic pain induced by paclitaxel in mice. Pain137, 520–531 (2008).
   PubMed Web of Science ®Google Scholar
• Kadiroglu AK, Sit D, Kayabasi H, Tuzcu AK, Tasdemir N, Yilmaz ME. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. J. Diabetes Complicat.22, 241–245 (2008).
   PubMed Web of Science ®Google Scholar
• Smith T, Nicholson RA. Review of duloxetine in the management of diabetic peripheral neuropathic pain. Vasc. Health Risk Manag.3, 833–844 (2007).
   PubMedGoogle Scholar
• Gilron I, Coderre TJ. Emerging drugs in neuropathic pain. Expert. Opin. Emerg. Drugs12, 113–126 (2007).
   PubMed Web of Science ®Google Scholar
• Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat. Neurosci.10, 1361–1368 (2007).
   PubMed Web of Science ®Google Scholar
• Niederberger E, Geisslinger G. Proteomics in neuropathic pain research. Anesthesiology108, 314–323 (2008).
   PubMed Web of Science ®Google Scholar
• Endo T, Spenger C, Hao J et al. Functional MRI of the brain detects neuropathic pain in experimental spinal cord injury. Pain138(2), 292–300 (2008).
   Google Scholar
• Chen FY, Tao W, Li YJ. Advances in brain imaging of neuropathic pain. Chin. Med. J. (Engl.)121, 653–657 (2008).
   Google Scholar
• Siniscalco D, Rossi F, Maione S. Molecular approaches for neuropathic pain treatment. Curr. Med. Chem.14, 1783–1787 (2007).
   PubMed Web of Science ®Google Scholar
• Jain KK. Cell therapy for pain. Expert Opin. Biol. Ther. (2008) (In press).
   Google Scholar
• Jain KK. Gene therapy for pain. Expert Opin. Biol. Ther. (2008) (In press).
   Google Scholar
• Sol JC, Li RY, Sallerin B et al. Intrathecal grafting of porcine chromaffin cells reduces formalin-evoked c-Fos expression in the rat spinal cord. Cell Transplant.14, 353–365 (2005).
   PubMed Web of Science ®Google Scholar
• Zhou H, Aziza J, Sol JC et al. Cell therapy of pain: Characterization of human fetal chromaffin cells at early adrenal medulla development. Exp. Neurol.198, 370–381 (2006).
   PubMed Web of Science ®Google Scholar
• Cejas PJ, Martinez M, Karmally S et al. Lumbar transplant of neurons genetically modified to secrete brain-derived neurotrophic factor attenuates allodynia and hyperalgesia after sciatic nerve constriction. Pain86, 195–210 (2000).
   PubMed Web of Science ®Google Scholar
• Glorioso JC, Mata M, Fink DJ. Gene therapy for chronic pain. Curr. Opin. Mol. Ther.5, 483–488 (2003).
   PubMed Web of Science ®Google Scholar
• Hao S, Mata M, Wolfe D et al. Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Ann. Neurol.57, 914–918 (2005).
   PubMed Web of Science ®Google Scholar
• Wolfe D, Hao S, Hu J et al. Engineering an endomorphin-2 gene for use in neuropathic pain therapy. Pain133, 29–38 (2007).
   PubMed Web of Science ®Google Scholar
• Dorn G, Patel S, Wotherspoon G et al. siRNA relieves chronic neuropathic pain. Nucleic Acids Res.32, e49 (2004).
   PubMed Web of Science ®Google Scholar
• Mikami M, Yang J. Short hairpin RNA-mediated selective knockdown of NaV1.8 tetrodotoxin-resistant voltage-gated sodium channel in dorsal root ganglion neurons. Anesthesiology103, 828–836 (2005).
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Kitamura T, Sekiguchi M et al. Involvement of EphB1 receptor/EphrinB2 ligand in neuropathic pain. Spine32, 592–598 (2007).
   Google Scholar
• Vit JP, Ohara PT, Bhargava A, Kelley K, Jasmin L. Silencing the Kir4.1 potassium channel subunit in satellite glial cells of the rat trigeminal ganglion results in pain-like behavior in the absence of nerve injury. J. Neurosci.28, 4161–4171 (2008).
   PubMed Web of Science ®Google Scholar
• Schafers M, Sommer C. Anticytokine therapy in neuropathic pain management. Expert Rev. Neurother.7, 1613–1627 (2007).
   PubMedGoogle Scholar
• White FA, Jung H, Miller RJ. Chemokines and the pathophysiology of neuropathic pain. Proc. Natl Acad. Sci. USA104, 20151–20158 (2007).
   PubMed Web of Science ®Google Scholar
• Milligan ED, Sloane EM, Watkins LR. Glia in pathological pain: a role for fractalkine. J. Neuroimmunol.198, 113–120 (2008).
   Google Scholar
• Piao ZG, Cho IH, Park CK et al. Activation of glia and microglial p38 MAPK in medullary dorsal horn contributes to tactile hypersensitivity following trigeminal sensory nerve injury. Pain121, 219–231 (2006).
   PubMed Web of Science ®Google Scholar
• Weston AD, Hood L. Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. J. Proteome Res.3, 179–196 (2004).
   PubMed Web of Science ®Google Scholar
• Materi W, Wishart DS. Computational systems biology in drug discovery and development: methods and applications. Drug Discov. Today12, 295–303 (2007).
   PubMed Web of Science ®Google Scholar
• Jain KK. Personalised medicine. Curr. Opin. Mol. Ther.4, 548–558 (2002).
   PubMedGoogle Scholar
• Jain KK. Personalized Medicine: Scientific and Commercial Aspects. Jain PharmaBiotech Publications, Basel, Switzerland (2008).
   Google Scholar
• Jain KK. How will genomics affect the practice of neurology? Practical Neurology6, 44–51 (2007).
   Google Scholar
• Aurilio C, Pota V, Pace MC, Passavanti MB, Barbarisi M. Ionic channels and neuropathic pain: physiopathology and applications. J. Cell. Physiol.215, 8–14 (2008).
   Google Scholar
• Finnerup NB, Sindrup SH, Jensen TS. Chronic neuropathic pain: mechanisms, drug targets and measurement. Fundam. Clin. Pharmacol.21, 129–136 (2007).
   PubMedGoogle Scholar
• Ziegler D. Painful diabetic neuropathy: treatment and future aspects. Diabetes Metab. Res. Rev.24(Suppl. 1), S52–S57 (2008).
   Google Scholar